Anti-CXCR4 antibody and its use for the detection and diagnosis of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9518120
SERIAL NO

14235274

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a novel, isolated anti-CXCR4 antibody for use in the diagnosis of cancer. In particular, the antibody of the invention recognizes monomeric and homodimeric CXCR4, but not heterodimeric CXCR4.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PIERRE FABRE MEDICAMENT45 PLACE ABEL GANCE BOULOGNE-BILLANCOURT 92100

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Janin-Bussat, Marie-Claire Saint-Julien-en-Genevois, FR 5 17
Jouhanneaud, Alexandra Bonneville, FR 19 57
Klinguer-Hamour, Christine Groisy, FR 15 37

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00